Original Biomedicals Co (ROCO:6483) Revenue: NT$0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6483 Original Biomedicals Co Ltd ROCO:6483
38 GF Score
Price NT$13.60
! 3 Warning Signs
View Full Analysis

What is Original Biomedicals Co Revenue?

Original Biomedicals Co ROCO:6483 -1.09% 38 Revenue is NT$0.00 Mil as of Jun. 2026. GuruFocus rates ROCO:6483 with a GF Score™ of 38/100. The stock has 3 warning signs investors should review.

Original Biomedicals Co's revenue for the six months ended in Jun. 2026 was NT$0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.00 Mil. Original Biomedicals Co's Revenue per Share for the six months ended in Jun. 2026 was NT$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.00.

During the past 12 months, the average Revenue per Share Growth Rate of Original Biomedicals Co was -100.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 44.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 9 years, Original Biomedicals Co's highest 3-Year average Revenue per Share Growth Rate was 44.20% per year. The lowest was -88.00% per year. And the median was -21.90% per year.

Original Biomedicals Co  (ROCO:6483) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Original Biomedicals Co Revenue Related Terms

Original Biomedicals Co Revenue Historical Data

* Premium members only.

The historical data trend for Original Biomedicals Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Original Biomedicals Co Revenue Chart

Original Biomedicals Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec22 Dec23 Dec24 Dec25
Revenue
Get a 7-Day Free Trial Premium Member Only 0.00 0.11 0.04 0.00 0.38

Original Biomedicals Co Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.38 0.00 0.00

ROCO:6483 vs ZTS: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Original Biomedicals Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Original Biomedicals Co Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Original Biomedicals Co's Revenue distribution charts can be found below:

* The bar in red indicates where Original Biomedicals Co's Revenue falls into.


ROCO:6483
38GF Score
Original Biomedicals Co Ltd ROCO:6483
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Original Biomedicals Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of NT$0.00 Mil mean?
Original Biomedicals Co (ROCO:6483) has a Revenue of NT$0.00 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Original Biomedicals Co and its competitors.
Is Original Biomedicals Co's Revenue too high?
Original Biomedicals Co's current Revenue is NT$0.00 Mil. Overall, Original Biomedicals Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Original Biomedicals Co's Revenue compare to ZTS?
Original Biomedicals Co's Revenue of NT$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Original Biomedicals Co and its competitors. Original Biomedicals Co's current Revenue is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Original Biomedicals Co stock overvalued right now?
Original Biomedicals Co (ROCO:6483) has a current Revenue of NT$0.00 Mil. The current Revenue is NT$0.00 Mil. Original Biomedicals Co's overall GF Score™ is 38/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Original Biomedicals Co (ROCO:6483), the current Revenue is NT$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Original Biomedicals Co Business Description

Address No. 9, Nanke 2nd Road, 2 Floor-1, Xinshi District, Tainan, TWN, 74147
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
38GF Score

Get the complete analysis for ROCO:6483

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.60
Price